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Background: Despite the high mortality and morbidity resulting from acute respiratory infections (ARI) globally, there
are few data from low-income countries on costs of ARI to inform public health policy decisions We conducted a
prospective survey to assess costs of ARI episodes in selected primary, secondary, and tertiary healthcare facilities
in north India where no respiratory pathogen vaccine is routinely recommended.
Methods: Face-to-face interviews were conducted among a purposive sample of patients with ARI from healthcare
facilities. Data were collected on out-of-pocket costs of hospitalization, medical consultations, medications, diagnostics,
transportation, lodging, and missed work days. Telephone surveys were conducted two weeks after medical encounters
to ask about subsequent missed work and costs incurred. Costs of prescriptions and diagnostics in public facilities were
supplemented with WHO-CHOICE estimates of hospital bed costs. Missed work days were assigned cost based on the
national annual per capita income (US$1,104). Non-medically attended ARI cases were identified from an ongoing
community-based ARI surveillance project in Faridabad.
Results: During September 2012-March 2013, 1766 patients with ARI were enrolled, including 451 hospitalized patients,
1056 outpatients, and 259 non-medically attended patients. The total direct cost of an ARI episode requiring outpatient
care was US$4- $6 for public and $3-$10 for private institutions based on age groups. The total direct cost of an
ARI episode requiring hospitalized care was $54-$120 in public and $135-$355 in private institutions. The cost of
ARI among those hospitalized was highest among persons aged > = 65 years and lowest among children aged < 5 years.
Indirect costs due to missed work days were 16-25% of total costs. The direct out-of-pocket cost of hospitalized ARI was
34% of annual per capita income.
Conclusions: The cost of hospitalized ARI episodes in India is high relative to median per capita income. Data from this
study can inform evaluations of the cost effectiveness of proven ARI prevention strategies such as vaccination.
Keywords: Acute respiratory infections, Costs, Outpatient, Inpatient, Direct, Indirect, Public, PrivateBackground
Acute respiratory infections (ARI) are major public
health threats, especially among children aged less than
5 years who are at risk for severe illness. In 2010, an esti-
mated 120 million cases of pneumonia occurred globally
and 11.9 million cases of acute lower respiratory infec-
tions (ALRI) were associated with hospitalization [1].* Correspondence: Peasah_SK@Mercer.edu
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unless otherwise stated.Additionally, 99% of estimated ALRI deaths occurred in
developing countries [1]. In Asia, an estimated 1.3 million
children aged less than 5 years die from ALRI annually
[2]. Although most ARI studies in developing countries
have focused on children, there are studies on adults, es-
pecially on influenza infections in the elderly [3]. ARIs can
result from infection with bacteria such as Streptococcus
pneumoniae and Haemophilus influenzae or viruses such
as respiratory syncytial viruses and influenza viruses.
Effective vaccines against S pneumonia, H influenza, and
influenza viruses are now available and recommended in
many high-income countries but rarely recommended inThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ities, economic consideration, lack of public funding for
vaccination, have been cited as some of the contributing
factors for low adoption of influenza vaccination in
developing countries [5].
In addition to causing substantial morbidity and mortal-
ity, ARI also result in economic losses through increased
use of healthcare resources and loss in productivity.
Costs-of-illness studies provide critical information on
the economic impact of diseases, and inputs for evalua-
tions of cost-effectiveness of interventions. Combined
with burden of disease estimates, cost studies provide
data on disease impact to guide public health policy
decisions about evidence-based interventions for effect-
ively addressing public health threats [3]. Although the
cost of ARIs has been estimated in high-income countries
[6-8], there are few data on costs in low or middle income
countries where disease severity may be worse because of
delayed health-care seeking and where out-of-pocket costs
may have an even higher impact on already impoverished
populations [4,9]. Most of such studies in Southeast Asia
have been on pneumonia or influenza [10-13].
In India, the burden of ARI is high [14,15], but vaccines
against common causes of ARI are not part of the national
immunization schedule with the exception of measles
vaccine.
We conducted a multi-site cost-of-illness study in three
communities in India to document the economic impact
of ARI-related hospitalizations and outpatient visits by age
in public and private facilities, and patient costs for non-
medically attended ARI since prior data suggest that many
persons in India do not seek medical care for ARI [16,17].
Methods
Setting and sites
This study was conducted during September 2012 to
March 2013 at selected primary, secondary and tertiary
care facilities in the National Capital Region (New Delhi
and Faridabad) and Srinagar in Jammu-Kashmir state of
India. Twenty-four health facilities covering all three
levels of medical care participated in the study, including
4 tertiary, 9 secondary and 11 primary care facilities. Six
hospitals/clinics in Faridabad refused to participate
including four private tertiary level hospitals, one private
secondary level facility, and one public hospital.
Primary level facilities were defined as those providing
outpatient and emergency care only and not overnight ad-
missions. Secondary level facilities were defined as those
that provide both outpatient and inpatient care but lack
capacity to provide intensive care. Tertiary level facilities
were those capable of providing intensive care.
The non-medically attended portion of the study was
conducted only in the Faridabad site during the same
period as the medically-attended study. Participants werefrom an ongoing epidemiological study of respiratory
pathogens in four villages of Ballabgarh in Faridabad.Data collection
Data collectors visited each facility two to three times a
week. Patients attending participating healthcare facilities
on these days were eligible for enrollment if they provided
consent and met the case definition for ARI. ARI was
defined as per the European Center for Disease Prevention
and Control case definition [18] as acute onset within
seven days of at least one of cough, sore throat, shortness
of breath or coryza, plus a clinician’s diagnosis of an infec-
tion. Hospitalized patients were eligible for enrollment if
they were hospitalized at least overnight and ARI was the
primary diagnosis for the admission.
For inpatients, administered questionnaires were through
face-to-face interviews at admission and/or discharge,
followed by a telephone interview two weeks after dis-
charge. Inpatient face-to-face administered questionnaires
collected data on out-of-pocket cost of admission, medical
consultations, medications, diagnostic procedures, trans-
portation, and lodging fees. The telephone interviews cov-
ered missed workdays of both patients and caregivers and
any other information not available at discharge. For
outpatients, administered questionnaires were through
face-to-face interviews at the time of consultation, and
followed up with a telephone call two weeks after the visit.
Outpatient questionnaires collected data on consultation,
self-purchased prescriptions, diagnostic procedures, and
transportation. By definition, non-medically attended ARI
cases are those where the patient fulfils the case definition
of ARI and had not consulted any trained or untrained
medical personnel for his/her disease throughout the
episode. Questionnaires were administered to patients
with non-medically attended ARI at the time of the
household visit (if the episode is over) to collect data
on duration of symptoms, cost of self-medications and
any non-medical consultation (e.g. consultation with an
herbalist), and time taken off work for the illness. Un-
like the medically-attended cases, no follow-up tele-
phone interviews were conducted since indirect cost
was not considered.Valuation of costs
Direct cost was defined as medical cost (cost of admission,
consultation, medications, or diagnostics such as radio-
logic and laboratory studies) and non-medical cost (trans-
portation, and lodging fees). Direct cost components were
self-reported by patients during in-person or telephone
follow-up interviews. Indirect cost was defined as the
monetary value of lost earnings of adult patients and care-
givers of all age groups due to inability to perform regular
duties because of illness. Estimation of indirect cost was
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to maintain societal productivity.Analysis
For medically-attended patients, direct cost was calculated
as the sum of the direct medical and non-medical cost of
the current hospitalization and follow-up visits to health
facilities for the same ARI episode. Costs paid by the
patient were considered for medical encounters at pri-
vate facilities and by the patient and government at
public facilities. WHO-CHOICE estimates were used as a
proxy for the cost to the government in public facilities.
WHO-CHOICE estimates [19] are available for hospital
bed-cost per day in public inpatient facilities or cost of out-
patient visits in public outpatient facilities but exclude cost
of diagnostic procedures and medications. We used the ac-
tual cost paid out-of-pocket by patients for diagnostic pro-
cedures and medications (confirmed by medical records)
as a proxy for the cost of medications and diagnostic
procedures in both private and public facilities.
Direct medical cost in public facilities is the sum of out-
of-pocket cost paid by patients for diagnostic tests and
medications and the WHO-CHOICE estimates. For in-
patients, the cost to the government is the product of
WHO-CHOICE estimates [19] per hospital day and the
median days of hospitalization. For outpatients, WHO-
CHOICE estimates for outpatient facilities were used in
lieu of the consultation fee paid by the patient, because
WHO-CHOICE estimates better estimate the resources
used in these facilities than the token consultation fee
paid by the patient.
In calculations involving WHO-CHOICE estimates, all
public teaching hospitals were considered tertiary institu-
tions and other public hospitals were considered secondary
institutions. For outpatient estimates, WHO-CHOICE esti-
mates for secondary level hospitals were used for all publicTable 1 Characteristics and cost of acute respiratory infection





Pharmacy consultation1 25 (28%)
Purchased medication2 11 (13%)
Median days with symptoms (IQR) 7 days
(4-9 days)
Median cost of medications (IQR) US$ 1.1
($0.6-$1.9)
1Pharmacy consultations are normally free because the fees are part of the cost of
over-the-counter medications.
2Number of people (%) who bought medications.facility visits. The 2008-based year estimates were adjusted
to 2012 using the consumer price index (1.24) for India
[20]. Non-medically attended ARI direct cost was calcu-
lated as the sum of cost of non-medical expenditures and
self-purchased prescriptions.
Indirect cost was estimated as the product of missed
work days and the median per capita income of US$1,104
per year [21]. Missed work days of the patient were esti-
mated by adding two days to the reported length of
hospital stay (similar to Molinari et al. [22]).
Costs were calculated by study site, age group, level of
care, and institution type (public vs. private) to reduce
skewedness of summary results. Medians and interquar-
tile ranges for different subgroups are reported instead
of means because data were not normally distributed.
For example, the mean cost of admission in private
facilities was $266 (SD $402) but the median was $166
(IQR $108-$276). The exchange rate used for conversion
of Indian Rupees (INR) to US$ was 1INR = 0.016 US$ [23].
Ethical review
The study protocol was reviewed and approved by the In-
stitution Ethics Committee, All India Institute of Medical
Sciences, Ansari Nagar, New Delhi (Protocol ID: 6296 IRB
Registration number: IRB0000682 & FWA #00014191)
and the Institutional Ethics Committee, Sher-i-Kashmir
Institute of Medical Sciences, Srinagar (IRB00008643).
The Institutional Review Board of the US Centers for
Disease Control and Prevention relied on review of the





Overall, 259 participants with non-medically attended ARI
were enrolled; 88 (34%) were children aged <5 years andamong persons with non-medically attended acute
ct, India, N = 259
6- 17 years 18 to 64 years > = 65 years
n = 70 n = 80 n = 21
37 (53%) 15 (19%) 9 (43%)
- 2 (3%) 9 (43%)
21 (30%) 17 (21%) 4 (19%)
6 (9%) 9 (11%) 3 (14%)
7 days 8 days 9 days
(6-10 days) (6-10 days) (8-10 days)
US$1.3 US$1.3 US$1.1
($1.3-$1.6) ($0.9-$2.4) ($0.4-$1.3)
medications but reflect proportion who sort help from the pharmacy for
Peasah et al. BMC Public Health  (2015) 15:330 Page 4 of 921 (8%) were adults aged > = 65 years (Table 1). Partici-
pant gender was generally evenly balanced in each age
group except among participants aged 18-64 years,
85% of whom were women. The median duration of
non-medically attended ARI from symptom onset to
recovery varied from 7 to 9 days.
Medically-attended ARI (inpatient and outpatient)
Overall, 1,507 patients with medically-attended ARI were
enrolled in the study, including 451 (30%) inpatients and
1,056 (70%) outpatients (Table 2). Persons aged >65 years
accounted for the largest proportion of inpatients (259/
451, 47%), whereas persons aged 18-64 years accounted
for the largest proportion of outpatients (614/1056, 39%).
Housewives and unskilled laborers were the most com-
mon occupation among both inpatients (25% and 19%, re-
spectively) and outpatients (18% and 14%). The majority
of inpatients (331/451, 73%) and outpatients (528/1056,
50%) received medical care at tertiary care facilities, and
all participants from Srinagar were enrolled at tertiary care
facilities. Overall, the median length of hospitalization
among inpatients was 5 days, but median length ofTable 2 Baseline characteristics of inpatients and outpatients
2013, National Capital Region and Srinagar, India, N = 1507
Total Natio
Inpatients Outpatients Inpat
n = 451(%)3 n = 1056(%)3 n = 2
Age group
<=5 years 135 (30) 383 (36) 65 (30
6-17 years 19 (4) 136 (13) 14 (7)
18-64 years 136 (30) 409 (39) 71 (33
> = 65 years 161 (36) 131 (12) 65 (30
Male 259 (57) 614 (58) 151 (7
Occupation
Housewife 66 (25) 159 (18) 13 (8)
Unskilled 49 (19) 118 (14) 28 (18
Retired 34 (13) 41 (5) 19 (12
Skilled 11 (4) 63 (7) 4 (3)
Unemployed 8 (3) 36 (4) 8 (5)
Others1 95 (36) 459 (48) 88 (54
Facility level
Primary - 250 (24) -
Secondary 120 (27) 278 (26) 120 (5
Tertiary 331 (73) 528 (50) 95 (44
Facility type
Public 325 (72) 838 (79) 89 (41
Private 126 (28) 218 (21) 126 (5
Length of stay2 5(IQR 4-10) - 5(IQR
1Others include children and students 2Length of hospital stays Median (interquarti
30% of all participants who answered the question on age were 5 years or youngerhospitalization was higher in Srinagar than the National
Capital Region (9 days vs. 5 days). All of the inpatient
cases were classified as severe lower respiratory infection
by the admitting physicians. For outpatient cases majority
were upper respiratory infections. For example, in the
National capital region, 79% were regarded upper re-
spiratory infections mainly febrile acute respiratory illness
or influenza-like illnesses. Of the remaining 21% lower




Of all 259 participants, 19-30% visited a pharmacy for
possible over-the-counter medication consultation (de-
pending on age group), and 9-14% bought medications
after the consultation (Table 1).
Medically-attended outpatient ARI
Among outpatients, 22% (233/1056) had non-medical
consultations prior to their outpatient visits, and 30%
(317/1056) had medical consultations prior to the visit.with acute respiratory infection, August 2012-March
nal Capital Region4 Srinagar
ients Outpatients Inpatients Outpatients
15(%)3 n = 739(%)3 n = 236(%)3 n = 317(%)3
) 283 (38) 70 (30) 100 (31)
89 (12) 5 (2) 47 (15)
) 263 (36) 65 (28) 146 (46)
) 107 (14) 96 (40) 24 (8)
0) 464 (63) 108 (46) 150 (47)
78 (12) 53 (51) 81 (41)
) 87 (13) 21 (20) 31 (16)
) 39 (6) 15 (14) 2 (1)
42 (6) 7 (7) 21 (11)
36 (5) - -
) 377 (58) 8 (8) 107 (31)
250 (34) - -
6) 278 (38) - -
) 211 (28) 236 (100) 317 (100)
) 521 (71) 236 (100) 317 (100)
9) 218 (29) - -
4-7) - 9(IQR 6-12) -
le range) 3The percentage of respondents within a given variable: For example,
4National Capital Region Includes Delhi and Faridabad.
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up visits after the current outpatient visit. Almost every
outpatient visit resulted in costs for prescribed medica-
tions (97-100%), but very few outpatients underwent la-
boratory or radiological studies (1-15%). Although 13%
(141/1056) of patients and 21% (225/1056) of their care-
givers missed work due to participants’ illnesses, only 7%
lost money due to missed work (Table 3).
Medically-attended inpatient ARI
Among hospitalized children aged < 5 years, the most
common components of out-of-pocket cost at public fa-
cilities were post-discharge prescriptions (incurred by
89% of participants), laboratory studies (81%) and radio-
logic studies (84%) (Table 4). In private facilities, the
most common components for children age < 5 years
were laboratory studies (91%) and radiologic studies
(74%). Compared to patients in the public sector, patients
in the private sector were more likely to undergo labora-
tory investigation (83% vs. 94%, p < 0.01) but less likely to
have a post-discharge prescription (87% vs. 66%, p < 0.01).
Among inpatients in all age groups, admission to intensive
care units was infrequent, except among adults aged > =65
years at private institutions (12/38, 32%).
Direct, indirect, and total cost of ARI
Cost of ARI in non-medically-attended settings
Since patients are not charged consultation fee at the
pharmacy, the only reported cost was the cost of medica-
tions bought at the pharmacy. For those who bought med-
ications, the median cost of medications was US$1.30.
Cost of ARI in outpatient settings
The total direct cost of ARI episodes requiring outpatient
care was US$4-$6 for public and $3-$10 for private insti-
tutions based on age groups (Figure 1). ConsultationTable 3 Health resource utilization among outpatients with a
National Capital Region and Srinagar, India, N = 1056
<=5 years 6-17 y
Public Private Public
n = 262 n = 118 n = 110
(%)1 (%)1 (%) 1
Prior Non-Medical Consultation 43 (17) 39 (67) 24 (22)
Prior Medical Consultation 109 (41) 17 (14) 33 (30)
Follow-up Medical Consultation 76 (29) 31 (26) 39 (35)
Medications Prescribed 250 (98) 114 (97) 102 (98
Radiological Studies 9 (3) 4 (3) 10 (9)
Patient Missed Work - - -
Caregiver Missed Work 87 (34) 12 (10) 41 (38)
Patient/Caregiver Lost Money 5 (2) 5 (4) 1 (1%)
1The percentage of participants who answered ‘yes’ to the question (related to a givencosts in private facilities were similar to the WHO-
CHOICE estimates in public facilities. However, out-
of-pocket expenditures for direct medical cost in
public facilities (~US$1-2) were lower compared to
private institutions (US$2-5).
Costs of ARI in inpatient settings
Direct cost of ARI was twice as high in private (US$135-
$355) as public (US$54-$120) institutions, 2.5 times higher
in tertiary than secondary institutions, and increased with
increasing age. Of all age groups, the median direct cost of
ARI was highest in adults aged > =65 years in private facil-
ities (US$355) and public facilities (US$120) (Additional
file 1). Among children aged < 5 years, the median direct
cost of ARI was US$135 in private and US$54 in public in-
stitutions. Direct cost was 2 to 20 times higher than indir-
ect cost. As a proportion of median annual per capita
income in India (US$1,104 in 2013), the total cost of ARI
in inpatients ranged from 6% (IQR 5-9%) in secondary
level public institutions to 34% (IQR 20-65%) in among
adults aged > =65 years in private institutions. At public fa-
cilities, the estimated cost of a hospital-bed paid by the
government accounted for 67% of the total direct cost of
the hospitalization.
Indirect cost of ARI
Among outpatients, missed work days were most com-
mon among caregivers of children aged <5 years at pub-
lic facilities (128/373, 34%) and least common among
persons aged 17-64 years in private facilities (3/64, 5%)
(Table 3). However, only 7% (75/1056) of all participants
reported that they or their caregiver lost money due to
missed work.
Among all inpatients, 14% (62/451) reported that they
missed work due to their hospitalization and 61% (274/451)
reported that a caregiver missed work. A larger proportioncute respiratory infection, August 2012-March 2013,
ears 18-64 years > = 65 years
Private Public Private Public Private
n = 26 n = 345 n = 64 n = 121 n = 10
(%)1 (%)1 (%)1 (%)1 (%)1
4 (15) 83 (24) 12 (19) 25 (21) 3 (30)
10 (38) 84 (24) 14 (22) 46 (38) 4 (40)
6 (23) 54 (16) 5 (8) 35 (29) 1 (10)
) 26 (100) 333 (97) 64 (100) 117 (98) 10 (100)
2 (8) 42 (12) 2 (3) 18 (15) 1 (10)
- 125 (36) 6 (9) 9 (7) 1 (10)
2 (8) 60 (17) 3 (5) 19 (16) 1 (10)
3 (12) 51 (15) 4 (6) 5 (4) 1 (10)
variable) with all participants who answered the question as the denominator.
Table 4 Health resource utilization among inpatients with acute respiratory infection, August 2012-March 2013,
National Capital Region and Srinagar, India, N = 451
<=5 years 6 -17 years 18-64 years > = 65 years
Public Private Public Private Public Private Public Private
n = 100 n = 35 n = 10 n = 9 n = 92 n = 45 n = 123 n = 38
(%)1 (%)1 (%)1 (%)1 (%)1 (%)1 (%)1 (%)1
Prior Non-Medical Consultation 50 (50) 4 (11) 3 (30) 2 (22) 29 (32) 8 (18) 41 (3) 1 (3)
Prior Medical Consultation 55 (55) 18 (51) 3 (33) 7 (78) 32 (36) 14 (31) 39 (33) 6 (16)
ICU Admission 4 (4) 2 (6) 2 (20) - 3 (3) 6 (13) 1 (1) 12 (32)
Post Discharge Prescription 89 (89) 15 (43) 8 (89) 5 (56) 70 (76) 32 (71) 88 (86) 32 (84)
Laboratory Studies 81 (81) 32 (91) 6 (67) 9 (100) 63 (81) 41 (91) 88 (87) 37 (97)
Radiological Studies 84 (84) 26 (74) 8 (89) 7 (78) 50 (63) 40 (89) 64 (65) 37 (97)
Caregiver Lodged 6 (6) 2 (6) - 1 (11) 2 (2) 1 (2) 3 (3) 4 (11)
Patient Missed Work - - - - 34 (37) 17 (38) 4 (3) 7 (18)
Caregiver Missed Work 77 (77) 9 (26) 7 (78) 1 (11) 58 (71) 21 (47) 77 (75) 24 (63)
Patient/Caregiver Lost Money2 3 (3) - - - 21 (26) 12 (27) 2 (2) 1 (3)
1The percentage of participants who answered ‘yes’ to the question (related to a given variable) with all participants who answered the question as the denominator.
2Reported that either patient or caregiver lost money because they missed work.
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due to the illness at public facilities than private facilities
(77% vs. 26%, p < 0.01) (Table 4). Among adults aged 18-64
years, 37% (51/137) reported missing work due to their ill-
ness, 58% (79/137) reported that a caregiver missed work
due to their illness, and 24% (33/137) reported that either
they or a caregiver lost money due to missed work.
Estimated indirect cost was higher in public facilities
($24-$34) than in private facilities ($21) because median
length of hospitalization was longer in public compared
to private facilities (7 vs. 4 days) resulting in more
missed days of work. Indirect costs also accounted for aFigure 1 Median Costs (US$) of outpatient-ARI in northern India by alarger percentage of total costs in public compared to
private facilities (25% vs. 16%).
Discussion
Costs of acute respiratory infections studies in the South-
eastern Asia region are scanty and most of the studies
focus on pneumonia in children under 5 years or influ-
enza. Our study sought to provide a comprehensive over-
view of the cost of ARI; in different age groups, at
different levels of institutional care, in both private and
public institutions, and uniquely, the cost of non-medically
attended ARI cases. In addition, we compared the cost ofge and health sector.
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strate the economic impact of ARI on patients and their
families. Cost of ARI was substantial, particularly for ARI-
associated hospitalizations which were associated with costs
up to a third of median annual per capita income.
Costs incurred at private facilities were up to twice the
costs incurred at public facilities; consistent with prior
studies documenting higher costs at all levels of health-
care in the private sector compared to the public sector
[24,25]. Although WHO-CHOICE estimates were added
to the cost for public facilities to account for govern-
ment costs; the disparities in inpatient cost between the
two sectors remain substantial. Higher costs in the pri-
vate sector may be driven by differences in treatment
protocol, and contributors to higher costs in the private
sector need to be identified.
The direct medical cost of ARI among inpatients varied
substantially by age, similar to the findings of Zhou et al.
[26] in China ($231 in children to $2,263 in older adults).
The out-of-pocket inpatient cost was the highest among
adults aged > = 65 years, meanwhile the majority of adults
in this age group were either retired or indicated that they
were housewives. Although children aged <5 years in-
curred the lowest costs per ARI episode in both public
and private sectors, the burden of ARI pathogens (for
example influenza-associated hospitalizations and out-
patient visits) are high [4,27]. For example, although ro-
bust epidemiological data on ARI incidence in India are
not available, about a fourth of total deaths in < 5 year
olds are due to pneumonia [15]. Additionally, 90% of
almost 150 million new episodes of pneumonia identi-
fied yearly occur in developing countries [28]. There-
fore, overall cost of ARI among young children is likely
to be high despite the lower relative cost we found in
children. Immunization is listed as one of the potential
interventions for preventing pneumonia but scanty cost
data might be contributing to the lack of attention given
to vaccination of at-risk groups in developing countries
[29]. WHO’s Strategic Advisory Group of Experts on
immunization (SAGE), recommends global influenza
vaccination in targeted populations as an effective tool
to mitigate the impact of influenza pandemics. Efforts are
under way by the Global Vaccine Action Plan to promote
and increase the capacity of developing countries for
vaccination uptakes [30].
The indirect cost of ARI was substantially lower than
the direct cost, and most participants reported not los-
ing money from work absences. These findings are con-
sistent with findings from other cost studies in Asia. In
Hong Kong, Fitzner et al. found that indirect cost of
influenza in Hong Kong [31] was low, because most par-
ticipants visited the clinics during days off from work or
after work and the US, estimated that indirect costs were
approximately half of direct costs [17]. In contrast,Simmerman et al. [32] estimated that indirect and direct
costs of influenza were roughly equal in Thailand, and
studies from some European countries have documented
indirect costs up to 10 times higher than direct costs [33].
Given that our sample consisted of a significant number
of housewives and students who reported not losing
money due to the illness, there is the need for further
investigations into indirect cost of ARI in India since
that can substantially affect the total cost of ARI.
Although the overall cost of hospitalized ARI at pub-
lic facilities was largely driven by hospital-bed costs to
the government, many patients also reported paying
out-of-pocket for radiologic and diagnostic tests during
hospitalization and for post-hospitalization prescription
medications. Among patients with outpatient ARI and
non-medically attended ARI (mainly upper respiratory
infections), out-of-pocket costs were low with the me-
dian cost equivalent to 1-5% and 1% of the monthly per
capita income in India, respectively. Cost of Inpatient
ARI (mainly severe lower respiratory infections warranting
admission), however, can be substantial (6-34% of annual
per capita income in India).
Several limitations should be considered when interpret-
ing our findings. We used a purposive sample (a subset
sample with unique characteristics from a larger popula-
tion) from ongoing surveillance studies (mainly from
middle- to low-income clientele) and therefore, costs
might not be representative of the population studied.
Our study population also included a substantial num-
ber of housewives, retirees and students, adding to the
complexity of estimating loss productivity. Out-of-pocket
costs were self-reported and were not verified with
medical records. Additionally, all data on non-medically
attended ARI came from only the Faridabad site and
therefore the findings do not represent the other two
sites. Despite these limitations, we believe our study
also has several strengths. This was a prospective study
with a limited period of recall which minimized inaccurate
recall of self-reported costs. Additionally, this study esti-
mated costs in both the public and private sectors at all
levels of care and among all age groups in the second
highest populous nation globally.
Conclusions
The cost of ARI episodes was substantial in our study
communities, and should be considered when weighing
public health priorities. Approaches to reduce the cost
of treatment and strategies to reduce the morbidity load
would be helpful. Proven strategies to reduce the burden
including prevention strategies like influenza and pneumo-
coccal vaccination, should be encouraged and pursued. Our
data suggesting higher costs in older adults and children
can be considered in age-group-specific prevention and
treatment recommendations.
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